Previous Article | Next Article 
Journal of Virology, April 2001, p. 3483-3487, Vol. 75, No. 7
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.7.3483-3487.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
JC Virus-Specific Cytotoxic T Lymphocytes in
Individuals with Progressive Multifocal Leukoencephalopathy
Igor J.
Koralnik,1,2,*
Renaud A.
Du Pasquier,1,2 and
Norman L.
Letvin2
Department of
Neurology1 and Division of Viral
Pathogenesis, Department of Medicine,2 Beth
Israel Deaconess Medical Center, Harvard Medical School, Boston,
Massachusetts 02215
Received 27 October 2000/Accepted 19 December 2000
Progressive multifocal leukoencephalopathy (PML) is a demyelinating
disease of the central nervous system caused by a reactivation of the
polyomavirus JC (JCV) within a setting of immunosuppression. The nature
of the immune response that contains replication of this virus is
unknown. We have explored JCV-specific cellular immune responses in
patients with PML and control subjects. JCV antigen-stimulated
peripheral blood mononuclear cells (PBMC) of four human
immunodeficiency virus (HIV)-infected patients who were survivors of
PML and one HIV-uninfected patient recently diagnosed with PML lysed
autologous B-lymphoblastoid cell lines expressing either the JCV T
regulatory protein or the VP1 major capsid protein. This lysis was
mediated by CD8+ T lymphocytes and was major
histocompatibility complex class I restricted. These cells were
therefore cytotoxic T lymphocytes (CTL). JCV-specific CTL could not be
detected in PBMC of three HIV-infected PML patients who had progressive
neurologic disease and an eventual fatal outcome. These data suggest
that the JCV-specific cellular immune response may play a crucial role
in the containment of PML. This finding may also prove useful as a
favorable prognostic marker in the clinical management of these patients.
*
Corresponding author. Mailing address: Department of
Neurology, Beth Israel Deaconess Medical Center, RE-213, 330 Brookline Ave., Boston, MA 02215. Phone: (617) 667-1568. Fax: (617) 667-8210. E-mail: ikoralni{at}caregroup.harvard.edu.
Journal of Virology, April 2001, p. 3483-3487, Vol. 75, No. 7
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.7.3483-3487.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Yang, W, Beaudoin, E., Lu, L, Du Pasquier, R., Kuroda, M., Willemsen, R., Koralnik, I., Junghans, R.
(2007). Chimeric immune receptors (CIRs) specific to JC virus for immunotherapy in progressive multifocal leukoencephalopathy (PML). Int Immunol
19: 1083-1093
[Abstract]
[Full Text]
-
Choudry, B. A., Chan, J. W.
(2007). An Update on Monoclonal Antibody Therapies in Multiple Sclerosis. Journal of Pharmacy Practice
20: 167-180
[Abstract]
-
Aschermann, Z., Gomori, E., Kovacs, G. G., Pal, E., Simon, G., Komoly, S., Marodi, L., Illes, Z.
(2007). X-linked Hyper-IgM Syndrome Associated With a Rapid Course of Multifocal Leukoencephalopathy. Arch Neurol
64: 273-276
[Abstract]
[Full Text]
-
Berger, J R
(2006). Natalizumab and progressive multifocal leucoencephalopathy. Ann Rheum Dis
65: iii48-iii53
[Abstract]
[Full Text]
-
Chen, Y., Trofe, J., Gordon, J., Du Pasquier, R. A., Roy-Chaudhury, P., Kuroda, M. J., Woodle, E. S., Khalili, K., Koralnik, I. J.
(2006). Interplay of Cellular and Humoral Immune Responses against BK Virus in Kidney Transplant Recipients with Polyomavirus Nephropathy.. J. Virol.
80: 3495-3505
[Abstract]
[Full Text]
-
Van Assche, G., Van Ranst, M., Sciot, R., Dubois, B., Vermeire, S., Noman, M., Verbeeck, J., Geboes, K., Robberecht, W., Rutgeerts, P.
(2005). Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease. NEJM
353: 362-368
[Abstract]
[Full Text]
-
Du Pasquier, R. A., Schmitz, J. E., Jean-Jacques, J., Zheng, Y., Gordon, J., Khalili, K., Letvin, N. L., Koralnik, I. J.
(2004). Detection of JC Virus-Specific Cytotoxic T Lymphocytes in Healthy Individuals. J. Virol.
78: 10206-10210
[Abstract]
[Full Text]
-
Du Pasquier, R. A., Kuroda, M. J., Zheng, Y., Jean-Jacques, J., Letvin, N. L., Koralnik, I. J.
(2004). A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain
127: 1970-1978
[Abstract]
[Full Text]
-
Comoli, P., Basso, S., Azzi, A., Moretta, A., De Santis, R., Del Galdo, F., De Palma, R., Valente, U., Nocera, A., Perfumo, F., Locatelli, F., Maccario, R., Ginevri, F.
(2003). Dendritic Cells Pulsed with Polyomavirus BK Antigen Induce Ex Vivo Polyoma BK Virus-Specific Cytotoxic T-Cell Lines in Seropositive Healthy Individuals and Renal Transplant Recipients. J. Am. Soc. Nephrol.
14: 3197-3204
[Abstract]
[Full Text]
-
Du Pasquier, R. A., Kuroda, M. J., Schmitz, J. E., Zheng, Y., Martin, K., Peyerl, F. W., Lifton, M., Gorgone, D., Autissier, P., Letvin, N. L., Koralnik, I. J.
(2003). Low Frequency of Cytotoxic T Lymphocytes against the Novel HLA-A*0201-Restricted JC Virus Epitope VP1p36 in Patients with Proven or Possible Progressive Multifocal Leukoencephalopathy. J. Virol.
77: 11918-11926
[Abstract]
[Full Text]
-
Du Pasquier, R.A., Corey, S., Margolin, D.H., Williams, K., Pfister, L.-A., De Girolami, U., Mac Key, J.J., Wuthrich, C., Joseph, J. T., Koralnik, I.J.
(2003). Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology
61: 775-782
[Abstract]
[Full Text]
-
Koralnik, I. J., Du Pasquier, R. A., Kuroda, M. J., Schmitz, J. E., Dang, X., Zheng, Y., Lifton, M., Letvin, N. L.
(2002). Association of Prolonged Survival in HLA-A2+ Progressive Multifocal Leukoencephalopathy Patients with a CTL Response Specific for a Commonly Recognized JC Virus Epitope. J. Immunol.
168: 499-504
[Abstract]
[Full Text]